CIK 0001728328
- Emerging growth company
Mentari Therapeutics, Inc.
Sign in to watch- Ticker
- MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 981428279
- Phone
- +1 781-887-5080
- Business address
- 221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
- Former names
- InMed Pharmaceuticals Inc.
- 4 Open-market sale Consultant sold 240 shares at $0.18 ($42)
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Delisting notice · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 37,500 shares at $0.39 ($14,625)
Page 10 of 27 · 538 filings